Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women

African ancestry and higher prevalence of triple-negative breast cancer

(2010) Azadeh Stark et al.   CANCER

Determination ofHER2amplification in primary breast cancer using dual-colour chromogenicin situhybridization is comparable to fluorescencein situhybridization: a European multicentre study involving 168 specimens

(2010) Tomás García-Caballero et al.   HISTOPATHOLOGY

Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer

(2009) Michaela Frye et al.   CANCER LETTERS

Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome

(2009) S. E. Elsheikh et al.   CANCER RESEARCH

Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer

(2009) Dezheng Huo et al.   JOURNAL OF CLINICAL ONCOLOGY

Characteristics and prognosis for molecular breast cancer subtypes in Chinese women

(2009) Jing Zhao et al.   JOURNAL OF SURGICAL ONCOLOGY

Ancestral links of Chesapeake Bay region African Americans to specific Bight of Bonny (West Africa) microethnic groups and increased frequency of aggressive breast cancer in both regions

(2008) Fatimah L. C. Jackson   AMERICAN JOURNAL OF HUMAN BIOLOGY

Early onset of breast cancer in a group of British black women

(2008) R L Bowen et al.   BRITISH JOURNAL OF CANCER

Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor–coregulator interactions

(2008) J Wen et al.   ONCOGENE

Breast Cancer in Chinese Women Younger than Age 40: Are They Different from Their Older Counterparts?

(2008) Ava Kwong et al.   WORLD JOURNAL OF SURGERY

Prognosis of Japanese Breast Cancer Based on Hormone Receptor and HER2 Expression Determined by Immunohistochemical Staining

(2008) Hiroo Nakajima et al.   WORLD JOURNAL OF SURGERY

The Ethnic Profile of Triple-Negative Breast Cancer

(2008) Susan J. Cleator et al.   Oncology Research and Treatment